(c) 2024 PillSync.com

Rosuvastatin calcium 40 MG Oral Tablet

1 INDICATIONS AND USAGE Pediatric use information for patients 7 to 17 years of age is approved for AstraZeneca’s CRESTOR (rosuvastatin calcium) tablets. However, due to AstraZeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Rosuvastatin calcium tablet is an HMG Co-A reductase inhibitor indicated for: adult patients with hypertriglyceridemia as an adjunct to diet ( 1.3 ) adult patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet ( 1.4 ) adult patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB ( 1.5 ) Limitations of use ( 1.8 ) : Rosuvastatin calcium tablets have not been studied in Fredrickson Type I and V dyslipidemias. 1.3 Hypertriglyceridemia Rosuvastatin calcium tablets are indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. 1.4 primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Rosuvastatin calcium tablets are indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia). 1.5 Adult Patients with homozygous familial hypercholesterolemia Rosuvastatin calcium tablets are indicated as adjunctive therapy to other lipid-lowering treatments (e.g., LDL apheresis) or alone if such treatments are unavailable to reduce LDL-C, Total-C, and ApoB in adult patients with homozygous familial hypercholesterolemia. 1.8 Limitations of Use Rosuvastatin has not been studied in Fredrickson Type I and V dyslipidemias.

par pharmaceutical, inc.


4 years ago OVAL WHITE par 263 Rosuvastatin calcium 40 MG Oral Tablet

OVAL WHITE par 263

16 HOW SUPPLIED Rosuvastatin calcium tablets are supplied as: 5 mg: light red, round biconvex tablet, debossed “par” on one side and “260” on the other. NDC 49884-260-09 Bottles of 90 10 mg: white to off white, round biconvex tablet, debossed “par” on one side and “261” on the other. NDC 49884-261-09 Bottles of 90 20 mg: light blue, round biconvex tablet, debossed “par” on one side and “262” on the other. NDC 49884-262-09 Bottles of 90 40 mg: white to off white, oval shape, biconvex tablet, debossed “par” on one side and “263” on the other. NDC 49884-263-11 Bottles of 30 Storage Store at controlled room temperature, 20º to 25º C (68º to 77º F) [see USP Controlled Room Temperature]. Protect from moisture.


More pills like OVAL par 263












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site